Trial Profile
Efficacy and tolerability of azelnidipine versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2011
Price :
$35
*
At a glance
- Drugs Azelnidipine (Primary) ; Losartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 14 Jan 2011 New trial record